CANCER GENETICS INC - COM (CGIX)

CUSIP: 13739U104

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
1,066,711
Share change
-507,231
Total reported value
$8,332,802
Price per share
$7.81
Number of holders
28
Value change
-$3,152,225
Number of buys
14
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q1 2015

As of 31 Mar 2015, CANCER GENETICS INC - COM (CGIX) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,066,711 shares. The largest 10 holders included VANGUARD GROUP INC, Millrace Asset Group, Inc., Granite Investment Partners, LLC, TURNER INVESTMENTS, L.P., GRUBER & MCBAINE CAPITAL MANAGEMENT LLC, ARDSLEY ADVISORY PARTNERS, Sterneck Capital Management, LLC, ROYCE & ASSOCIATES LLC, GEODE CAPITAL MANAGEMENT, LLC, and Commonwealth Equity Services, Inc. This page lists 28 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.